The Emerging Potential of the Apelin-APJ System in Heart Failure

Journal of Cardiac Failure
Jonathan R DalzellJohn J V McMurray

Abstract

The apelin-APJ system is a novel neurohormonal pathway, with studies to date suggesting that it may be of pathophysiologic relevance in heart failure and may indeed be a viable therapeutic target in this syndrome. This interest is driven primarily by the demonstration of its vasodilator, inotropic, and aquaretic actions as well as its apparent antagonistic relationship with the renin-angiotensin system. However, its promise is heightened further by the observation that, unlike other and more established cardioprotective pathways, it appears to be down-regulated in heart failure, suggesting that augmentation of this axis may have a powerful effect on the heart failure syndrome. We review the literature regarding the apelin-APJ system in heart failure and suggest areas requiring further research.

References

Oct 30, 1998·Biochemical and Biophysical Research Communications·K TatemotoM Fujino
May 22, 2001·Journal of Neurochemistry·A ReauxC Llorens-Cortès
May 30, 2001·European Journal of Heart Failure·C BerryJ J McMurray
Jan 30, 2002·The Journal of Biological Chemistry·Chad VickersPeter Tummino
Aug 14, 2003·Biochemical and Biophysical Research Communications·Gábor FöldesMiklós Tóth
Sep 10, 2003·Circulation·Mary M ChenThomas Quertermous
Dec 20, 2003·Basic Research in Cardiology·Stephan von HaehlingStefan D Anker
Jul 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nadia De MotaCatherine Llorens-Cortes
Sep 15, 2004·Circulation·Mark F BerryY Joseph Woo
Dec 29, 2004·Cardiovascular Research·Euan A AshleyThomas Quertermous
Jan 29, 2005·Endocrinology·Jérémie BoucherPhilippe Valet
May 24, 2005·Pharmacology & Therapeutics·Matthias J Kleinz, Anthony P Davenport
Nov 3, 2005·Regulatory Peptides·Jens Peter GoetzeLennart Friis-Hansen
Nov 10, 2005·Regulatory Peptides·Yue-Xia JiaYong-Fen Qi
Feb 9, 2006·European Journal of Heart Failure·Kwok Shiong ChongTheresa A McDonagh
Mar 4, 2006·Circulation Research·Ursula Danilczyk, Josef M Penninger
May 30, 2006·The Journal of Endocrinology·Christopher J CharlesA Mark Richards
Aug 8, 2006·European Journal of Heart Failure·Pietro FranciaMassimo Volpe
Sep 19, 2006·Journal of the American College of Cardiology·Roland R van KimmenadeYigal M Pinto
Oct 24, 2006·European Journal of Pharmacology·Tieying DaiWei Dong Gao
Nov 23, 2006·Cellular & Molecular Biology Letters·Pavan AtluriY Joseph Woo
Dec 15, 2006·European Journal of Heart Failure·Mariantonietta CicoiraUNKNOWN Val-HeFT Investigators
Dec 21, 2006·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·L LiK Li
Feb 24, 2007·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Bogdan GurzuGheorghe Petrescu
Mar 8, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Veli-Pekka RonkainenPasi Tavi
May 1, 2007·Biochemical and Biophysical Research Communications·Klára FarkasfalviCesare M N Terracciano
Jul 14, 2007·Regulatory Peptides·Adely SalcedoGodofredo Diéguez
Aug 19, 2007·Heart·Arend Mosterd, Arno W Hoes
Nov 21, 2007·Trends in Cardiovascular Medicine·Oreste GualilloFrancisca Lago
Nov 21, 2007·Regulatory Peptides·Matthias J Kleinz, Gary F Baxter
Dec 18, 2007·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Wilfried MullensMarc Vanderheyden
Feb 15, 2008·Journal of the American Society of Nephrology : JASN·Michel AziziCatherine Llorens-Cortes

❮ Previous
Next ❯

Citations

Oct 16, 2016·Journal of the American College of Cardiology·Jeffrey I MechanickW Timothy Garvey
Mar 27, 2018·Diabetes/metabolism Research and Reviews·Weimin WangDa-Wei Gong
Jan 6, 2018·Frontiers in Physiology·Ying ZhouLiang Yin
Feb 19, 2020·Expert Opinion on Therapeutic Patents·Conrad Fischer
Jan 18, 2018·European Journal of Clinical Investigation·Rodrigo A Fraga-SilvaRafaela F da Silva
Mar 5, 2020·Cellular and Molecular Life Sciences : CMLS·Jialong YanLinxi Chen
Dec 14, 2018·The Journal of Clinical Hypertension·Elias SanidasJohn Barbetseas
Jun 27, 2019·Annals of the New York Academy of Sciences·Eric MarsaultMannix Auger-Messier
Nov 4, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Andrea L FrumpTim Lahm
May 21, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Alexander E Berezin, Alexander A Berezin
May 21, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Dennis K Lee, Ori Nevo
Sep 26, 2017·Clinical and Experimental Pharmacology & Physiology·Farzaneh RostamzadehSiyavash Joukar
May 1, 2020·Current Cardiology Reviews·Yaniel Castro-Torres, Richard E Katholi
Nov 21, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Satvik MareeduGopal J Babu
Aug 26, 2021·Scientific Reports·Tereza HavlenovaVojtech Melenovsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.